Stockscreener 앱 받기
34.45
3.45%
1.15
시간 외 거래:
34.45
Agios Pharmaceuticals Inc 주식(AGIO)의 최신 뉴스
Trend Review: Will Agios Pharmaceuticals Inc face regulatory challengesQuarterly Growth Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals and other big stocks moving higher on Tuesday - MSN
Valuation Update: Is Agios Pharmaceuticals Inc stock good for income investorsExit Point & Fast Moving Stock Trade Plans - baoquankhu1.vn
Alpha Thalassemia (US, EU4, UK, and Japan) Market Insights, Epidemiology, and Forecasts 2022-2025 & 2025-2036 - GlobeNewswire Inc.
Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - ADVFN
Agios gains on plans to seek FDA accelerated nod for Pyrukynd label expansion - MSN
Published on: 2026-04-10 10:39:14 - baoquankhu1.vn
Exit Recap: Is Agios Pharmaceuticals Inc stock good for income investors2026 Macro Impact & Fast Moving Trade Plans - baoquankhu1.vn
What Agios Pharmaceuticals (AGIO)'s FDA-Backed Accelerated Path for Mitapivat in Sickle Cell Disease Means For Shareholders - Sahm
(AGIO) Risk Channels and Responsive Allocation - Stock Traders Daily
Why Agios Pharmaceuticals Stock Is Up More Than 21% Today - AOL.com
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and Agios Pharma (AGIO) - The Globe and Mail
Agios Pharmaceuticals Insider Sells $102,047 in Stock - National Today
Agios Pharmaceuticals Insider Sells $102K in Shares - National Today
Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sells $113,848.80 in Stock - MarketBeat
Agios Pharmaceuticals (NASDAQ:AGIO) CFO Cecilia Jones Sells 3,141 Shares - MarketBeat
Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sells $113,224.02 in Stock - marketbeat.com
AGIO: JP Morgan Raises Price Target to $36, Maintains Neutral Ra - GuruFocus
Agios Pharmaceuticals CLO sells $113,848 in stock By Investing.com - Investing.com Canada
Jones Cecilia, Agios Pharmaceuticals CFO, sells $109k in stock By Investing.com - Investing.com India
Jones Cecilia, Agios Pharmaceuticals CFO, sells $109k in stock - Investing.com
Agios (NASDAQ: AGIO) CLO exercises 8,500 PSUs and sells shares for taxes - Stock Titan
[Form 4] AGIOS PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan
Agios (NASDAQ: AGIO) CFO exercises PSUs, automatic share sale for taxes - Stock Titan
Agios (AGIO) CCO vests 8,500 PSUs, sells 3,262 shares for taxes - Stock Titan
Agios (NASDAQ: AGIO) exec sells shares to cover PSU tax obligations - Stock Titan
Agios (AGIO) CEO settles performance units, sells 19K shares to cover taxes - Stock Titan
JPMorgan Chase & Co. Raises Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $36.00 - MarketBeat
Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET - Bitget
J.P. Morgan Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating, Announces Target Price $36 - Moomoo
Short Squeeze: Is Agios Pharmaceuticals Inc stock overvalued or fairly priced2026 Key Highlights & Intraday High Probability Alerts - baoquankhu1.vn
Agios to Host First Quarter 2026 Financial Results Conference Call - National Today
Agios will webcast first-quarter results before markets open April 29 - Stock Titan
A Look At Agios Pharmaceuticals (AGIO) Valuation As It Pursues Accelerated FDA Approval For Mitapivat - Sahm
AGIO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
AGIO SEC FilingsAgios Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Agios Pharmaceuticals, Inc. (AGIO) stock price, news, quote and history - Yahoo Finance Australia
Agios to seek accelerated approval in US of oral mitapivat for SCD - Sickle Cell Disease News
[144] AGIOS PHARMACEUTICALS, INC. SEC Filing - Stock Titan
AGIO (NASDAQ: AGIO) pre-sale notice — 3,141 RSU shares vesting - Stock Titan
Insider sale and RSU vesting at AGIO (Nasdaq: AGIO) — 2,959 shares - Stock Titan
RSU vesting triggers proposed Common Stock sale for AGIO (AGIO) - Stock Titan
AGIO (NASDAQ: AGIO) affiliate files to sell 2,940 shares after RSU vesting - Stock Titan
3,280 RSUs vest; James Burns sold 5,218 shares — AGIO (NASDAQ: AGIO) - Stock Titan
Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last? - qz.com
Agios Pharmaceuticals (NASDAQ:AGIO) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says - MarketBeat
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD - The Globe and Mail
AGIO Shares Climb as Mitapivat Advances Toward Fast-Track Approval for SCD - bitget.com
Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky - Finviz
A Look At Agios Pharmaceuticals (AGIO) Valuation After Recent Share Price Momentum - Yahoo Finance
Earnings Recap: Is Agios Pharmaceuticals Inc a good ESG investment2026 Sector Review & Fast Moving Trade Plans - baoquankhu1.vn
Agios to pursue accelerated approval for mitapivat in sickle cell By Investing.com - Investing.com South Africa
H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $65 - Moomoo
The Surprise FDA Move That Sent Two Biotechs Rallying - Investor's Business Daily
2.69%
0.25%
자본화:
|
볼륨(24시간):